AbbVie
-$0.57 (-0.38%) Today
-$0.25 (-0.17%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AbbVie and other ETFs, options, and stocks.
About ABBV
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions.
CEO
Richard A. Gonzalez
Employees
50,000
Headquarters
North Chicago, Illinois
Founded
2011
ABBV Key Statistics
Market cap
265.07B
Price-Earnings ratio
21.51
Dividend yield
3.61
Average volume
6.52M
High today
$150.04
Low today
$147.75
Open price
$149.50
Volume
8.40M
52 Week high
$175.91
52 Week low
$105.56
ABBV News
Analyst ratings
72%
of 25 ratings
Buy
72%
Hold
24%
Sell
4%
ABBV Earnings
$0.00
$1.11
$2.22
$3.33
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Jul 29, Pre-Market